PI3
Elafin
Also known as: cementoin, ELAF_HUMAN, ELAFIN, ESI, SKALP, WAP3, WFDC14
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P19957
- Gene
- PI3
- Ensembl
- ENSG00000124102
- Chromosome
- 20
- Canonical length
- 117 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes an elastase-specific inhibitor that functions as an antimicrobial peptide against Gram-positive and Gram-negative bacteria, and fungal pathogens. The protein contains a WAP-type four-disulfide core (WFDC) domain, and is thus a member of the WFDC domain family. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the centromeric cluster. Expression of this gene is upgulated by bacterial lipopolysaccharides and cytokines. [provided by RefSeq, Oct 2014]
Canonical amino-acid sequenceUniProt
117 residues, UniProt reviewed canonical sequence.
>P19957|PI3
1 MRASSFLIVV VFLIAGTLVL EAAVTGVPVK GQDTVKGRVP FNGQDPVKGQ VSVKGQDKVK
61 AQEPVKGPVS TKPGSCPIIL IRCAMLNPPN RCLKDTDCPG IKKCCEGSCG MACFVPQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PI3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 2,188 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 2,188 nTPM
- tonsil: 1,968 nTPM
- vagina: 1,669 nTPM
- cervix: 1,451 nTPM
- salivary gland: 529 nTPM
- colon: 119 nTPM
Single-cell type
- esophageal apical cells: 14,978 nCPM
- gastric progenitor cells: 2,757 nCPM
- esophageal suprabasal cells: 1,656 nCPM
- endometrial secretory cells: 696 nCPM
- suprabasal keratinocytes: 361 nCPM
- colonocytes: 187 nCPM
Immune cell
- neutrophil: 1,775 nTPM
- eosinophil: 1.7 nTPM
- total PBMC: 0.6 nTPM
- classical monocyte: 0.4 nTPM
- basophil: 0.3 nTPM
- intermediate monocyte: 0.3 nTPM
Brain region
- thalamus: 40 nTPM
- cerebral cortex: 25 nTPM
- pons: 15 nTPM
- choroid plexus: 2.1 nTPM
- basal ganglia: 0.7 nTPM
- hypothalamus: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.66
- gnomAD pLI
- 0.17
- gnomAD missense Z
- 0.1
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- endopeptidase inhibitor activity
- serine-type endopeptidase inhibitor activity
- structural constituent of skin epidermis
Cellular components
Protein domainsUniProt · Pfam · InterPro
- WAP-type 'four-disulfide core' domain
- Elafin-like superfamily
- WAP four-disulfide core domain
- WAP-type (Whey Acidic Protein) 'four-disulfide core'
- Seminal vesicle protein I
- Trappin protein transglutaminase-binding repeat
- Trappin protein transglutaminase binding domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PI3 as an antibody target. Whether an autoantibody or antibody against PI3 could matter depends on whether native PI3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PI3 is annotated as secreted, so native PI3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PI3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...